Is Coloplast A/S (CLPBY) a Buy, Sell, or Hold?
OTC : CLPBY
Coloplast A/S — News
$6.7 USD
-$0.06 (-0.89%)
- Volume
- 39K
- Average Volume
- 457K
- Market Capitalization
- $15.1B
- P/E Ratio
- 45.97
- Dividend Yield
- 5.36%
- Price Target
- $14.45
- Year High
- $10.03
- Year Low
- $5.64
- Day High
- —
- Day Low
- —
- Payout Ratio
- $2.46
- Current Ratio
- $1.75
| Source | Headline |
|---|---|
|
Coloplast: Went 'BUY' A Bit Early
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls, and regulatory shifts—have driven shares down, but core fundamentals and inelastic product demand remain intact. CLPBY now trades at a historically low sub-18x P/E, offering a 5.76% yield and potential 12–13% annualized growth until 2028E, supporting a buy rating. seekingalpha.com - 2026-05-16 10:37:53 |
|
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-05-12 12:10:51 |
